RenalGuard system in high-risk patients for contrast-induced acute kidney injury.

Journal: American heart journal
PMID: 26920598

Abstract

BACKGROUND: High urine flow rate (UFR) has been suggested as a target for effective prevention of contrast-induced acute kidney injury (CI-AKI). The RenalGuard therapy (saline infusion plus furosemide controlled by the RenalGuard system) facilitates the achievement of this target.

Authors

  • Carlo Briguori
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy. Electronic address: carlobriguori@clinicamediterranea.it.
  • Gabriella Visconti
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy.
  • Michael Donahue
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy.
  • Francesca De Micco
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy.
  • Amelia Focaccio
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy.
  • Bruno Golia
    Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy.
  • Giuseppe Signoriello
    Department of Mental Health and Preventive Medicine, Second University of Naples, Naples, Italy.
  • Carmine Ciardiello
    HT MED, Pozzuoli, Naples, Italy.
  • Elvira Donnarumma
    IRCCS SDN, Naples, Italy.
  • Gerolama Condorelli
    Department of Cellular and Molecular Biology and Pathology, "Federico II" University of Naples, Naples, Italy.

Keywords

External Resources

Popular Topics
Recent Journals